Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - alfentanil hydrochloride, quantity: 5.438 mg - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid - alfentanil gh injection is indicated for intravenous use by specialist anaesthetists and their trainees as:,? an analgesic supplement given by incremental intravenous boluses or continuous infusion; and,? an anaesthetic induction agent where in patients undergoing in-patient surgery, when endotracheal intubation and controlled ventilation are to be used.,because of its rapid onset and short duration of action, intravenous alfentanil gh injection is particularly suited as a narcotic analgesic for short procedures and outpatients, provided that the patients are maintained under appropriate post-operative surveillance. however, intravenous alfentanil gh injection is also useful as an analgesic supplement for procedures of medium to long duration, since periods of very painful stimuli can be easily overcome by administration of small increments of alfentanil gh injection or by adapting the infusion rate.

Israel - English - Ministry of Health

lapidot medical import and marketing ltd - remifentanil as hydrochloride - powder for concentrate for solution for injection / infusion - remifentanil as hydrochloride 1 mg - remifentanil - remifentanil b.braun is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision .remifentanil b.braun is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.

Israel - English - Ministry of Health

lapidot medical import and marketing ltd - remifentanil as hydrochloride - powder for concentrate for solution for injection / infusion - remifentanil as hydrochloride 1 mg - remifentanil - remifentanil b.braun is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision .remifentanil b.braun is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.

Israel - English - Ministry of Health

lapidot medical import and marketing ltd - remifentanil as hydrochloride - powder for concentrate for solution for injection / infusion - remifentanil as hydrochloride 2 mg - remifentanil - remifentanil b.braun is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision .remifentanil b.braun is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.

Israel - English - Ministry of Health

lapidot medical import and marketing ltd - remifentanil as hydrochloride - powder for concentrate for solution for injection / infusion - remifentanil as hydrochloride 2 mg - remifentanil - remifentanil b.braun is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision .remifentanil b.braun is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.

Israel - English - Ministry of Health

lapidot medical import and marketing ltd - remifentanil as hydrochloride - powder for concentrate for solution for injection / infusion - remifentanil as hydrochloride 5 mg - remifentanil - remifentanil b.braun is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision .remifentanil b.braun is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.

Israel - English - Ministry of Health

lapidot medical import and marketing ltd - remifentanil as hydrochloride - powder for concentrate for solution for injection / infusion - remifentanil as hydrochloride 5 mg - remifentanil - remifentanil b.braun is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision .remifentanil b.braun is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - remifentanil hydrochloride 1.097mg equivalent to 1 mg remifentanil;   - powder for injection - 1 mg - active: remifentanil hydrochloride 1.097mg equivalent to 1 mg remifentanil   excipient: glycine hydrochloric acid - remifentanil-aft is indicated as an analgesic agent: · for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery · for the continuation of analgesia in the immediate post-operative period during transition to longer acting analgesia · for the provision of analgesia and sedation in mechanically ventilated intensive care patients.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - remifentanil hydrochloride 2.194mg equivalent to 2 mg remifentanil;   - powder for injection - 2 mg - active: remifentanil hydrochloride 2.194mg equivalent to 2 mg remifentanil   excipient: glycine hydrochloric acid - remifentanil-aft is indicated as an analgesic agent: · for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery · for the continuation of analgesia in the immediate post-operative period during transition to longer acting analgesia · for the provision of analgesia and sedation in mechanically ventilated intensive care patients.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - remifentanil hydrochloride 5.485mg equivalent to 5 mg remifentanil;   - powder for injection - 5 mg - active: remifentanil hydrochloride 5.485mg equivalent to 5 mg remifentanil   excipient: glycine hydrochloric acid - remifentanil-aft is indicated as an analgesic agent: · for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery · for the continuation of analgesia in the immediate post-operative period during transition to longer acting analgesia · for the provision of analgesia and sedation in mechanically ventilated intensive care patients.